Patients showing more DNA methylation at some genome sites found to be more likely to fail to respond to metformin
A team of researchers affiliated with multiple institutions in Europe has found a connection between patients who show more DNA methylation at some genome sites and a higher likelihood of failing to respond to metformin. ...